1. Quality of life in patients with primary aldosteronism: Gender differences in untreated and long-term treated patients and associations with treatment and aldosterone
- Author
-
Konstantina Apostolopoulou, Felix Beuschlein, Sabine Gerum, Evelyn Fischer, Stephan Endres, Martin Reincke, Heike Künzel, Sebastian Schulz, Volker Brand, Martin Bidlingmaier, Anna Pallauf, and Katrin Merkle
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,medicine.drug_class ,medicine.medical_treatment ,Spironolactone ,Plasma renin activity ,Gastroenterology ,chemistry.chemical_compound ,Primary aldosteronism ,Quality of life ,Germany ,Surveys and Questionnaires ,Internal medicine ,Hyperaldosteronism ,Renin ,Humans ,Medicine ,Registries ,Aldosterone ,Biological Psychiatry ,Aged ,Mineralocorticoid Receptor Antagonists ,business.industry ,Adrenalectomy ,Middle Aged ,medicine.disease ,humanities ,Psychiatry and Mental health ,Endocrinology ,chemistry ,Mineralocorticoid ,Quality of Life ,Female ,business ,Psychopathology - Abstract
Psychopathological symptoms in patients with primary aldosteronism (PA) have been reported. In a cross-sectional design the self-reported physical and mental condition among patients with PA of the German Conn's Registry differently treated during the course of the disease were analysed. 27 patients were investigated before initiation of specific therapy (U), 56 patients were on chronic mineralocorticoid antagonist treatment (MRA) and 49 patients had undergone adrenalectomy (ADX). Patient's quality of life was analysed with the SF-12 for a Physical (PCS) and a Mental Component (MCS). Statistically significant lower scores for PCS were found for female PA patients treated with MRA in comparison to ADX patients and the German reference population (36.4 ± 11.1 vs. 49.1 ± 10.9 (p = 0.024) vs. 47.9 ± 9.7 (p = 0.001)), respectively. Concerning MCS, untreated female patients scored significantly lower (36.5 ± 7.4) than females from the German population (51.3 ± 8.4, p = 0.000). Furthermore, untreated females appear to differ significantly from MRA and ADX females, scoring the lowest reading (U vs. MRA: p = 0.029; U vs. ADX: p = 0.005). Significant correlations were found between plasma aldosterone (r = -0.819, p = 0.013) and the MCS and between plasma renin concentration and MCS (r = -0.938, p = 0.001) in female MRA patients. In summary, PA patients report a worse physical and mental condition than the one reported for the German reference population. Untreated and mineralocorticoid antagonist treated patients report the lowest readings. Females were found to be more impaired than males in QoL. MRA treatment seems to affect the MCS of female patients.
- Published
- 2012